We’re going to get a little meta here, so be warned.
Take a look at the headline of this post. For those of you unfamiliar with the symbols to the left and right of the words, those are quotation marks. What that means is that we’ve taken those two sentences from another source. And here is that other source, a blog post from Tahseen Consulting titled — yes, you guessed it, “Is Imitation the Sincerest Form of Flattery? Not Without Proper Attribution.”
Apparently, the last group of authors who liked Tahseen’s words enough to use them did so without that whole attribution thing. Here, let us demonstrate attribution again, this time using the WordPress block-quote function. From the post: Continue reading “Is Imitation the Sincerest Form of Flattery? Not Without Proper Attribution.”
Another retraction has appeared up for frequent fliers Jun Li, Kailun Zhang and Jiahong Xia at Huazhong Science and Technology University in Wuhan, China.
We’ve covered them twice before, for a variety of retractions, corrections, and expressions of concern.
The retraction, in Clinical and Experimental Immunology, upgrades an expression of concern published earlier this year, and is the team’s fourth.
Here’s the notice for “CCR5 blockade in combination with rapamycin prolongs cardiac allograft survival in mice”: Continue reading Serial figure fakers have expression of concern upgraded to a retraction
It’s an unusual move: Pediatric Allergy and Immunology has switched out the cover image in the online versions of its March issue, after realizing that likening allergies to a tsunami while Japan is struggling with the devastating effects of a real-life disaster could be “open to misinterpretation.” From an editor’s note: Continue reading Unfortunate timing: Journal retracts cover image, citing tsunami in Japan
Last week’s big Retraction Watch news — which got us quoted in the New York Times — was a Nature paper by Amy Wagers and Shane Mayack. The now-retracted paper suggested that the aging of stem cells could be reversed, and Blood has issued a notice of concern about a second paper.
Now comes news about another stem cell finding. The International Journal of Urology has retracted a 2009 paper by Japanese researchers who claimed to have used stem cells derived from fatty tissue to treat urinary incontinence in two men. The men had developed bladder problems after undergoing surgery to remove their cancerous prostates.
According to the editor’s note, the article Continue reading Another stem cell paper retracted, for “breach of established ethical guidelines”
Over the summer, while searching for some studies and evidence for various treatments, my wife, a television writer and producer, noticed something she thought unusual enough to flag for me. The titles of a number of Cochrane Library reviews started with “WITHDRAWN.”
The Cochrane Library is the world’s leading publisher of systematic reviews, which gather all of the high-quality evidence on a given subject and offer a rigorous analysis of whether a given test or treatment works. It’s an invaluable resource. (Shameless plug: Join the Association of Health Care Journalists, where I’m treasurer, and access to the $285-per-year Cochrane subscription is included.)
Retraction Watch was curious about what “WITHDRAWN” meant, since “withdrawal” is often used synonymously with retraction. Cochrane updates its reviews regularly, as new evidence surfaces, of course. But these abstracts didn’t say anything about new reviews.
We asked Jen Beal, who handles media relations for Wiley, the Cochrane Library’s publisher. She responded: Continue reading Progressive: How the Cochrane Library handles updates-in-progress